Literature DB >> 10417485

Antibiotic resistance: a current perspective.

K F Barker1.   

Abstract

Mesh：

Year:  1999        PMID： 10417485      PMCID： PMC2014301          DOI： 10.1046/j.1365-2125.1999.00997.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  79 in total

Review 1.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 2.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Preparing for battle against vancomycin resistance.

Authors:  P M Rowe
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

4.  Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.

Authors:  T I Nicas; D L Mullen; J E Flokowitsch; D A Preston; N J Snyder; R E Stratford; R D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

5.  In-vitro activity of two glycylcyclines against enterococci resistant to other agents.

Authors:  A P Fraise; N Brenwald; J M Andrews; R Wise
Journal:  J Antimicrob Chemother       Date:  1995-06       Impact factor: 5.790

6.  Simultaneous identification of bacterial virulence genes by negative selection.

Authors:  M Hensel; J E Shea; C Gleeson; M D Jones; E Dalton; D W Holden
Journal:  Science       Date:  1995-07-21       Impact factor: 47.728

Review 7.  Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

Authors:  W A Craig
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

8.  Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.

Authors:  W J Weiss; N V Jacobus; P J Petersen; R T Testa
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

9.  Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria.

Authors:  G Malanoski; L Collins; C T Eliopoulos; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

10.  Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.

Authors:  J M Entenza; H Drugeon; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191
View more
  19 in total

1.  Antimicrobial utilization and bacterial resistance at three different hospitals.

Authors:  V Vlahović-Palcevski; M Morović; G Palcevski; L Betica-Radić
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 2.  Bacterial Transcription as a Target for Antibacterial Drug Development.

Authors:  Cong Ma; Xiao Yang; Peter J Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2016-01-13       Impact factor: 11.056

Review 3.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 4.  Linezolid: a review of its use in the management of serious gram-positive infections.

Authors:  C M Perry; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.

Authors:  R M Schiffelers; G Storm; M T ten Kate; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

6.  Microbiology and antibiotic sensitivity of head and neck space infections of odontogenic origin.

Authors:  Inderdeep Singh Walia; Rajiv M Borle; D Mehendiratta; Abhilasha O Yadav
Journal:  J Maxillofac Oral Surg       Date:  2013-02-19

7.  Institutional microbial analysis of odontogenic infections and their empirical antibiotic sensitivity.

Authors:  Aneesh Sebastian; P G Antony; Mathew Jose; Arun Babu; Jubin Sebastian; Abraham Kunnilathu
Journal:  J Oral Biol Craniofac Res       Date:  2019-02-13

Review 8.  Antimicrobial peptides and peptidomimetics - potent therapeutic allies for staphylococcal infections.

Authors:  Haroon Mohammad; Shankar Thangamani; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

9.  Isolation of Staphylococcus aureus and antibiotic-resistant Staphylococcus aureus from residential indoor bioaerosols.

Authors:  Angelina Gandara; Linda C Mota; Carissa Flores; Hernando R Perez; Christopher F Green; Shawn G Gibbs
Journal:  Environ Health Perspect       Date:  2006-12       Impact factor: 9.031

10.  The occurrence of bioactive micromonosporae in aquatic habitats of the Sunshine Coast in Australia.

Authors:  Glen P Eccleston; Peter R Brooks; D Ipek Kurtböke
Journal:  Mar Drugs       Date:  2008-06-05       Impact factor: 5.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.